PrimeCell Advanced Therapy Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

  • Investments
  • 1

PrimeCell Advanced Therapy General Information

Description

Developer of regenerative medicine focused on discovering and clinical testing of biological drugs and medicinal technologies. The company's scientific and manufacturing infrastructure utilizes technologies to develop, process and manufacture human cell and tissue products that change genes and cells parameters to support the regeneration of human tissues and organs, thereby enabling physicians and patients with new treatments that use human cells and new materials such as nanomaterials to treat serious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • BioIncubator 4MEDi, University Hospital
  • Dr. Slabihoudka 11
  • Ostrava, 708 00
  • Czech Republic
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Corporate Office
  • BioIncubator 4MEDi, University Hospital
  • Dr. Slabihoudka 11
  • Ostrava, 708 00
  • Czech Republic

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PrimeCell Advanced Therapy Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PrimeCell Advanced Therapy‘s full profile, request access.

Request a free trial

PrimeCell Advanced Therapy Patents

PrimeCell Advanced Therapy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023174463-A1 Method of preparation of a biological therapeutic product based on perinatal tissue, and the product Inactive 15-Mar-2022
EP-3851852-A1 Method for separation of sperm with undamaged intact heads from sperm with damaged heads and somatic cells Inactive 17-Jan-2020
EP-3851853-A1 Method for separation of sperm with undamaged intact heads from sperm with damaged heads and somatic cells Inactive 17-Jan-2020
EP-4090972-A1 Method for separation of sperm with undamaged intact heads from sperm with damaged heads and somatic cells Inactive 17-Jan-2020
US-20230044560-A1 Method for separation of sperm with undamaged intact heads from sperm with damaged heads and somatic cells Pending 17-Jan-2020 B01D57/00
To view PrimeCell Advanced Therapy’s complete patent history, request access »

PrimeCell Advanced Therapy Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PrimeCell Advanced Therapy Investments (1)

PrimeCell Advanced Therapy’s most recent deal was a Buyout/LBO with Rodinná Banka Perinatálních a Mesenchymálních Buněk for . The deal was made on 21-Dec-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Rodinná Banka Perinatálních a Mesenchymálních Buněk 21-Dec-2020 Buyout/LBO Other Healthcare Services
To view PrimeCell Advanced Therapy’s complete investments history, request access »

PrimeCell Advanced Therapy Exits (1)

PrimeCell Advanced Therapy’s most recent exit was on 21-Dec-2020 from Rodinná Banka Perinatálních a Mesenchymálních Buněk. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Rodinná Banka Perinatálních a Mesenchymálních Buněk 21-Dec-2020 Completed
  • 2 buyers
To view PrimeCell Advanced Therapy’s complete exits history, request access »

PrimeCell Advanced Therapy Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Rodinná Banka Perinatálních a Mesenchymálních Buněk Ostrava, Czech Republic 2009

PrimeCell Advanced Therapy FAQs

  • When was PrimeCell Advanced Therapy founded?

    PrimeCell Advanced Therapy was founded in 2007.

  • Where is PrimeCell Advanced Therapy headquartered?

    PrimeCell Advanced Therapy is headquartered in Ostrava, Czech Republic.

  • What is the size of PrimeCell Advanced Therapy?

    PrimeCell Advanced Therapy has 100 total employees.

  • What industry is PrimeCell Advanced Therapy in?

    PrimeCell Advanced Therapy’s primary industry is Biotechnology.

  • Is PrimeCell Advanced Therapy a private or public company?

    PrimeCell Advanced Therapy is a Private company.

  • What is PrimeCell Advanced Therapy’s current revenue?

    The current revenue for PrimeCell Advanced Therapy is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process